Navigation Links
PRC Clinical To Attend Major Industry Conferences And Meet Sponsor Companies In The San Diego Biotech Hub

PRC Clinical, a Clinical Trial Management Expert CRO, will be attending three major conferences to develop new business relationships with local sponsors in southern California. The Clinical Trial Management Expert CRO seeks to introduce more California-based sponsors to its services to facilitate their drug development processes and regulatory pathways.

  • Stem Cell Meeting on the Mesa on October 7-9 in La Jolla, CA: ARM’s annual event attracts more than 800 industry-leading professionals for partnering opportunities, interactive panels, and scientific lectures in the field of regenerative medicine and stem cell research. PRC Clinical officially joined the Alliance for Regenerative Medicine (ARM) this year. The ARM counts more than 200 pioneering organizations, fostering research, development, investment, and commercialization of transformational treatments and cures for patients worldwide.
  • MAGI Clinical Research Conference on Oct 11-14 in San Diego, CA: MAGI (Model Agreements & Guidelines International) is streamlining clinical research by standardizing best practices for clinical operations, business and regulatory compliance. Over 100 sessions and workshops will offer practical tips in a coherent program for operations, regulatory compliance, contracts and budgets.
  • Outsourcing in Clinical Trials (OCT) Southern California Conference on October 14-15 in La Jolla, CA: The OCT Conference features high-level speakers from industry’s leading companies using outsourcing examples from their own experiences of clinical development including pharmaceutical, medical devices and biomedical research.

San Diego has been ranked third amongst the top 15 cities for biotech venture funding by Fierce Biotech last year. "A local and experienced drug development partner is essential for growing sponsor companies to optimize their clinical and regulatory pathways” states Curtis Head, CEO of PRC Clinical. “This series of California conferences is the opportunity for PRC Clinical to meet with local sponsors seeking qualified partners in California".

As an expert drug development partner, PRC Clinical works with sponsor companies from consulting to protocol design, Site Selection, Trial monitoring, Data Management, CTMS, Biostatistics as well as Regulatory Guidance and Submissions.

About PRC Clinical

PRC Clinical is a Silicon Valley-based Clinical Trial Management Expert CRO supporting phase I-IV clinical studies for pharmaceutical and medical device companies globally. Founded in 2003, PRC Clinical offers Clinical Trial Management services including Site Monitoring, Quality Assurance, Drug Safety, Clinical Project Management, Payment Services, Biostatistics, Data Management, EDC and CTMS. PRC clinical has significant CRO experience in conducting phase I-IV clinical studies in a wide range of therapeutic areas: CNS, Neurology, Pain, GI, Device, Anti-infective, Cardiovascular, Pulmonary, Oncology, Ophthalmology, ALS, Parkinson, and Stem cells. Visit, call 1-877-519-6001, or email info(at)prcclinical(dot)com.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
2. Portages Biohavens lead drug candidate clears FDA Investigational New Drug Application (IND) review and clinical studies to begin
3. Lee Biosolutions Announces Exclusive Clinical Trial Supply Agreement with St. Teresa Medical
4. Simulation Significantly Impacts Respiratory Systems Device Design By Reducing Clinical Trial Tests
5. Guanabenz Accelerates ALS Disease Progression in Preclinical Laboratory Experiments
6. Inhibikase Therapeutics, Inc. Launches Clinical Study For Survivors Of PML
7. Verified Clinical Trials Chosen by National Institute on Drug Abuse To Stop Dual Enrollment In Clinical Trials & Improve Safety & Data Quality In Ongoing Clinical Trial
8. 2015-2019 Global Automated Microbiology Market - The Level of Automation in The Microbiology Laboratory Has Been Lagging Behind That Of Other Major Clinical Laboratory Segments
9. European Automated Microbiology Market 2015-2019 - The Level of Automation in the Microbiology Laboratory Has Been Lagging Behind That of Other Major Clinical Laboratory Segments
10. Germany Automated Microbiology Market 2015-2019 - The Driving Force Behind the Need for Rapid Reporting of Microbiological Test Results is the Clinical Relevance in a Time of Financial Austerity
11. France Automated Microbiology Market 2015-2019 - The Level of Automation in the Microbiology Laboratory has Been Lagging Behind that of Other Major Clinical Laboratory Segments
Post Your Comments:
(Date:7/31/2020)... , ... July 29, 2020 , ... R3 Stem Cell ... for only $3950. With 50 million stem cells total, patients may choose which extremities ... therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord ...
(Date:7/31/2020)... ... July 29, 2020 , ... Diversified Technologies, ... that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. , ... or two switches in a push-pull configuration; yielding fast fall time for a ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... that they have entered into a strategic partnership whereby Catalent will provide support ...
(Date:7/31/2020)... ... , ... The SDX® Respiratory Gating System , trusted ... its 20th anniversary of worldwide use. Introduced in the US over the past ... of Pennsylvania, University of Michigan, University of Maryland, University of California San Francisco—and ...
Breaking Biology Technology:
(Date:7/2/2020)... Md. (PRWEB) , ... July ... ... Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use ... one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The article, ...
(Date:6/28/2020)... ... June 25, 2020 , ... Genedata, ... that it has entered into a multi-year contract with Merus N.V., a ... translational and clinical research strategy to discover and develop ground-breaking drugs. The ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... gene-to-protein and monoclonal antibody development services, today announced that the company has ... services to the pharmaceutical, diagnostics, and research industries. The decision to pursue ...
Breaking Biology News(10 mins):